Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1982 Apr;57(4):287–291. doi: 10.1136/adc.57.4.287

Gonadal function after combination chemotherapy for Hodgkin's disease in childhood.

E Whitehead, S M Shalet, P H Jones, C G Beardwell, D P Deakin
PMCID: PMC1627621  PMID: 7082042

Abstract

The effect of quadruple chemotherapy (mustine, vincristine, procarbazine, and prednisolone) on gonadal function was investigated in 15 males and 2 females treated for Hodgkin's disease during childhood. The 2 females have regular menstrual cycles with evidence of ovulation in one. Twelve of the males have shown normal progression of pubertal development since completing their treatment. Nine out of 10 late pubertal or adult subjects had small testes but only one developed gynaecomastia. All 4 prepubertal subjects had normal basal and peak gonadotrophin responses to luteinising hormone-releasing hormone. Nine of the 12 subjects studied during puberty or adulthood had either an increased basal serum follicle-stimulating hormone (FSH) level or an exaggerated FSH response to luteinising hormone-releasing hormone. Each of the 6 males who provided semen for analysis was azoospermic after an interval of between 2.4 and 8 (mean 5.3) years after completion of treatment. We conclude that severe testicular damage is common after treatment with mustine, vincristine, procarbazine, and prednisolone in childhood. The germinal epithelium is particularly vulnerable and the resultant azoospermia is likely to be irreversible. The Leydig cells are less susceptible to cytotoxic-induced damage. Pubertal development is normal and there is no indication for androgen replacement therapy.

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C., Hopper B. R., Lasley B. L., Yen S. S. A simple method for the assay of eight steroids in small volumes of plasma. Steroids. 1976 Aug;28(2):179–196. doi: 10.1016/0039-128x(76)90108-2. [DOI] [PubMed] [Google Scholar]
  2. Buchanan J. D., Fairley K. F., Barrie J. U. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet. 1975 Jul 26;2(7926):156–157. doi: 10.1016/s0140-6736(75)90059-8. [DOI] [PubMed] [Google Scholar]
  3. Chapman R. M., Sutcliffe S. B., Malpas J. S. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA. 1979 Oct 26;242(17):1877–1881. [PubMed] [Google Scholar]
  4. Chapman R. M., Sutcliffe S. B., Rees L. H., Edwards C. R., Malpas J. S. Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet. 1979 Feb 10;1(8111):285–289. doi: 10.1016/s0140-6736(79)90701-3. [DOI] [PubMed] [Google Scholar]
  5. Dickerman Z., Prager-Lewis R., Laron Z. Response of plasma LH and FSH to synthetic LH-RH in children at various pubertal stages. Am J Dis Child. 1976 Jun;130(6):634–638. doi: 10.1001/archpedi.1976.02120070060011. [DOI] [PubMed] [Google Scholar]
  6. Lee I. P., Dixon R. L. Antineoplastic drug effects on spermatogenesis studied by velocity sedimentation cell separation. Toxicol Appl Pharmacol. 1972 Sep;23(1):20–41. doi: 10.1016/0041-008x(72)90201-3. [DOI] [PubMed] [Google Scholar]
  7. Lee I. P., Dixon R. L. Effects of procarbazine on spermatogenesis determined by velocity sedimentation cell separation technique and serial mating. J Pharmacol Exp Ther. 1972 May;181(2):219–226. [PubMed] [Google Scholar]
  8. Mancini R. E., Lavieri J. C., Muller F., Andrada J. A., Saraceni D. J. Effect of prednisolone upon normal and pathologic human spermatogenesis. Fertil Steril. 1966 Jul-Aug;17(4):500–513. doi: 10.1016/s0015-0282(16)36008-3. [DOI] [PubMed] [Google Scholar]
  9. Richter P., Calamera J. C., Morgenfeld M. C., Kierszenbaum A. L., Lavieri J. C., Mancini R. E. Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer. 1970 May;25(5):1026–1030. doi: 10.1002/1097-0142(197005)25:5<1026::aid-cncr2820250506>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  10. Shalet S. M., Beardwell C. G., Jacobs H. S., Pearson D. Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) 1978 Dec;9(6):483–490. doi: 10.1111/j.1365-2265.1978.tb01505.x. [DOI] [PubMed] [Google Scholar]
  11. Shalet S. M., Beardwell C. G., Morris-Jones P. H., Pearson D. Pituitary function after treatment of intracranial tumours in children. Lancet. 1975 Jul 19;2(7925):104–107. doi: 10.1016/s0140-6736(75)90006-9. [DOI] [PubMed] [Google Scholar]
  12. Shalet S. M. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev. 1980 Sep;7(3):141–152. doi: 10.1016/s0305-7372(80)80028-4. [DOI] [PubMed] [Google Scholar]
  13. Shalet S. M., Hann I. M., Lendon M., Morris Jones P. H., Beardwell C. G. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child. 1981 Apr;56(4):275–278. doi: 10.1136/adc.56.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sherins R. J., Olweny C. L., Ziegler J. L. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med. 1978 Jul 6;299(1):12–16. doi: 10.1056/NEJM197807062990103. [DOI] [PubMed] [Google Scholar]
  15. Sieber S. M., Correa P., Dalgard D. W., Adamson R. H. Carcinogenic and other adverse effects of procarbazine in nonhuman primates. Cancer Res. 1978 Jul;38(7):2125–2134. [PubMed] [Google Scholar]
  16. Whitehead E., Shalet S. M., Blackledge G., Todd I., Crowther D., Beardwell C. G. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer. 1982 Feb 1;49(3):418–422. doi: 10.1002/1097-0142(19820201)49:3<418::aid-cncr2820490304>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES